Neuralink, Elon Musk’s ambitious brain-computer interface (BCI) startup, has secured a massive $650 million in Series E funding as it enters a new phase of clinical trials with its groundbreaking neural implant.
The funding round drew participation from high-profile investors, including ARK Invest, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners, Founders Fund, and the Qatar Investment Authority (QIA). According to Semafor, this latest investment boosts Neuralink’s valuation to around $9 billion.
Telepathy Implant Already Helping Patients – and Aiming Higher
Neuralink’s flagship product, the Telepathy BCI, has already been successfully implanted in five patients suffering from severe paralysis. All of them managed to control computers, browse the web, play video games, and post on social media – using only their thoughts.
The company also confirmed:
🔹 Four ongoing clinical trials across three countries
🔹 Development of additional applications for vision and speech restoration
🔹 Official Breakthrough Device designation from the FDA
The Telepathy device uses ultrathin, flexible threads – thinner than a human hair – embedded directly into the brain. Each thread carries 1,024 electrodes, capturing neural signals and transmitting them wirelessly to external devices like laptops and smartphones.
What’s Next: Access, Innovation, and Human-AI Synergy
According to Neuralink, this new capital will accelerate:
🔹 Clinical testing and innovation,
🔹 Wider patient access,
🔹 Development of next-gen devices with deeper AI-human integration,
🔹 And recruitment of top-tier talent across engineering, neuroscience, and operations.
The team emphasized their mission to restore independence for people with unmet medical needs and push the boundaries of what brain-computer interfaces can achieve.
Global Trials and Neuroscience Partnerships
Clinical studies are already underway at top-tier neurological centers:
🔹 Barrow Neurological Institute
🔹 The Miami Project to Cure Paralysis
🔹 University Health Network (Toronto)
🔹 Cleveland Clinic Abu Dhabi
Neuralink says it’s investing heavily to expand the number of brain regions and neurons its devices can interface with – unlocking new dimensions of human potential.
Elon Musk has even pledged to personally receive a Neuralink implant, demonstrating his belief in its safety and long-term potential. He’s also repeatedly teased applications like restoring vision even in people lacking functional optic nerves.
The Race for the Brain Heats Up
Despite its head start, Neuralink faces rising competition, especially from U.S.-based Paradromics. Their device, Connexus, was tested during an epilepsy surgery, proving its ability to record high-resolution brain signals.
Paradromics claims its 420 micro-needles enable superior neural signal quality, especially for tasks like speech decoding. They plan to begin full-scale clinical trials by year-end, focused on restoring communication in people with ALS, stroke damage, or spinal cord injuries.
Other major BCI players include:
🔹 Synchron, which takes a less invasive approach via blood vessels
🔹 Precision Neuroscience, which places its interface on the brain’s surface (rather than penetrating it)
These methods are gentler but might offer lower resolution compared to deeper neuron-level connections used by Neuralink and Paradromics.
#Neuralink , #ElonMusk , #techinnovation , #worldnews , #Musk
Stay one step ahead – follow our profile and stay informed about everything important in the world of cryptocurrencies!
Notice:
,,The information and views presented in this article are intended solely for educational purposes and should not be taken as investment advice in any situation. The content of these pages should not be regarded as financial, investment, or any other form of advice. We caution that investing in cryptocurrencies can be risky and may lead to financial losses.“